Rationale, Opportunities, and Reality of Biosimilar Medications

Abstract

Biosimilars work like established therapeutic agents but have some dissimilarities based on differences in production. These agents should be less expensive than, but as effective as, their patented relatives, but several barriers keep the advantage from being realized.